non responders to semaglutide glp 1 Doctor, I'm not losing weight on the GLP1” 🛑👇🏻 When GLP-1 medications don't work the – Decoding the hallmarks of GLP-1RA

In April 2004, JHU reported that inhibition of FAS with C-75 altered food-intake, resulting in significant weight loss in animals, with no evidence of neurotoxicity

Statistical analyses were performed using GraphPad Prism (version 9.0, GraphPad Software, San Diego, CA, USA)

PMID: 3029331 | doi:10.1111/j.1471-4159.1987.tb05655.x Susi V et al

Across all semaglutide treatment arms, the most frequent AEs were gastrointestinal disorders (most commonly nausea, diarrhoea and vomiting), the majority of which were mild/moderate in severity

But heres the good news: There are ways to reduce the cost, even if you dont have health insurance